Cost-Effectiveness Analysis of Laboratory Monitoring in Newly Diagnosed Telogen Effluvium Patients

    Rhiannon C. Miller, Kaya L Curtis, Sajjad Abedian, Shari R. Lipner
    Image of study
    TLDR Targeted testing for telogen effluvium patients can save healthcare costs.
    The study "Cost-effectiveness analysis of laboratory monitoring in newly diagnosed telogen effluvium patients" evaluates the financial efficiency of various laboratory tests for patients with newly diagnosed telogen effluvium (TE). The research, conducted by Miller, Curtis, Abedian, and Lipner, involved analyzing 16,381 laboratory results. The findings suggest that many routine tests, such as complete blood count (CBC) and thyroid stimulating hormone (TSH) levels, may not be necessary for all TE patients, potentially leading to significant cost savings in healthcare. The study emphasizes the importance of targeted testing based on individual patient profiles to avoid unnecessary expenses.
    Discuss this study in the Community →

    Cited in this study

    1 / 1 results